Published in Inflamm Bowel Dis on May 01, 2009
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol (2010) 3.32
Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis (2009) 2.44
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations. J Clin Gastroenterol (2010) 1.64
Safety assessment of probiotics for human use. Gut Microbes (2010) 1.44
Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One (2012) 1.06
Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PLoS One (2012) 1.05
Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes (2013) 1.01
Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol (2011) 0.93
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol (2014) 0.92
Emerging drugs for the treatment of ulcerative colitis. Expert Opin Emerg Drugs (2009) 0.87
Gatekeepers of intestinal inflammation. Inflamm Res (2010) 0.85
Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer? Gut Microbes (2010) 0.83
Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications. Curr Nutr Food Sci (2013) 0.83
Maintaining adequate nutrition, not probiotic administration, prevents growth stunting and maintains skeletal muscle protein synthesis rates in a piglet model of colitis. Pediatr Res (2010) 0.79
Live and heat-killed probiotic: effects on chronic experimental colitis induced by dextran sulfate sodium (DSS) in rats. Int J Clin Exp Med (2015) 0.77
Safety and efficacy of Profermin® to induce remission in ulcerative colitis. World J Gastroenterol (2012) 0.75
Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence. Children (Basel) (2014) 0.75
Effects of probiotics (Vivomixx®) in obese pregnant women and their newborn: study protocol for a randomized controlled trial. Trials (2016) 0.75
The Probiotic VSL#3 Modulates Colonic Macrophages, Inflammation, and Microflora in Acute Trinitrobenzene Sulfonic Acid Colitis. J Histochem Cytochem (2017) 0.75
The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science (2009) 8.23
The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol (2006) 3.76
Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology (2007) 2.70
Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol (2008) 1.99
DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology (2004) 1.78
Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol (2014) 1.55
World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol (2012) 1.39
Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease. Inflamm Bowel Dis (2016) 1.39
5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK. Biochem J (2005) 1.35
Changes in metal levels and chromosome aberrations in the peripheral blood of patients after metal-on-metal hip arthroplasty. J Arthroplasty (2004) 1.24
Human gut microbiota and its relationship to health and disease. Nutr Rev (2011) 1.20
Recommendations for probiotic use-2011 update. J Clin Gastroenterol (2011) 1.19
The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Curr Gastroenterol Rep (2006) 1.15
Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr (2007) 1.15
The 1993 Canadian Association of Gastroenterology Strategic Plan: excellence in achievement. Can J Gastroenterol (2003) 1.14
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis (2009) 1.14
Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J Pharmacol Exp Ther (2003) 1.11
Does onsite cytotechnology evaluation improve the accuracy of endoscopic ultrasound-guided fine-needle aspiration biopsy? Can J Gastroenterol (2009) 1.10
Environment and the inflammatory bowel diseases. Can J Gastroenterol (2013) 1.07
Correlation of particular bacterial PCR-denaturing gradient gel electrophoresis patterns with bovine ruminal fermentation parameters and feed efficiency traits. Appl Environ Microbiol (2010) 1.06
Lipid metabolism, adipocyte depot physiology and utilization of meat animals as experimental models for metabolic research. Int J Biol Sci (2010) 1.00
Regional and age dependent changes in gene expression of Toll-like receptors and key antimicrobial defence molecules throughout the gastrointestinal tract of dairy calves. Vet Immunol Immunopathol (2012) 1.00
Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr (2006) 0.97
Changes in bacterial diversity associated with epithelial tissue in the beef cow rumen during the transition to a high-grain diet. Appl Environ Microbiol (2011) 0.95
Perspectives on super-shedding of Escherichia coli O157:H7 by cattle. Foodborne Pathog Dis (2014) 0.94
The congenital intrahepatic arterioportal fistula syndrome: elucidation and proposed classification. J Pediatr Gastroenterol Nutr (2006) 0.94
Distinct commensal bacteria associated with ingesta and mucosal epithelium in the gastrointestinal tracts of calves and chickens. FEMS Microbiol Ecol (2011) 0.94
Skeletal muscle stem cells from animals I. Basic cell biology. Int J Biol Sci (2010) 0.93
Non-specific abdominal pain and air pollution: a novel association. PLoS One (2012) 0.92
Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress. FASEB J (2011) 0.91
Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study. Liver Int (2009) 0.90
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease. Inflamm Bowel Dis (2010) 0.89
Adenosine is a negative regulator of NF-kappaB and MAPK signaling in human intestinal epithelial cells. Cell Immunol (2005) 0.88
Patient and parent satisfaction with a dietitian- and nurse- led celiac disease clinic for children at the Stollery Children's Hospital, Edmonton, Alberta. Can J Gastroenterol (2013) 0.87
cis-Urocanic acid attenuates acute dextran sodium sulphate-induced intestinal inflammation. PLoS One (2010) 0.86
The surface display of haemolysin from Vibrio harveyi on yeast cells and their potential applications as live vaccine in marine fish. Vaccine (2006) 0.86
Effect of calf starter feeding on gut microbial diversity and expression of genes involved in host immune responses and tight junctions in dairy calves during weaning transition. J Dairy Sci (2013) 0.86
Diagnostic criteria for eosinophilic esophagitis: a 5-year retrospective review in a pediatric population. J Pediatr Gastroenterol Nutr (2009) 0.86
The changing frequency of celiac disease diagnosed at the Stollery Children's Hospital. Can J Gastroenterol (2010) 0.86
Antisense oligonucleotides to poly(ADP-ribose) polymerase-2 ameliorate colitis in interleukin-10-deficient mice. J Pharmacol Exp Ther (2002) 0.86
Differential clustering of bowel biopsy-associated bacterial profiles of specimens collected in Mexico and Canada: what do these profiles represent? J Med Microbiol (2008) 0.86
Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can J Gastroenterol (2008) 0.85
Ambient ozone concentrations and the risk of perforated and nonperforated appendicitis: a multicity case-crossover study. Environ Health Perspect (2013) 0.85
Potential impact of mature adipocyte dedifferentiation in terms of cell numbers. Int J Stem Cells (2011) 0.85
A marine killer yeast against the pathogenic yeast strain in crab (Portunus trituberculatus) and an optimization of the toxin production. Microbiol Res (2006) 0.84
Postoperative complications and emergent readmission in children and adults with inflammatory bowel disease who undergo intestinal resection: a population-based study. Inflamm Bowel Dis (2014) 0.84
Combining T cells and IL-10: a new therapy for Crohn's disease? Gastroenterology (2002) 0.83
A randomized trial of topical anesthesia comparing lidocaine versus lidocaine plus xylometazoline for unsedated transnasal upper gastrointestinal endoscopy. Can J Gastroenterol (2010) 0.83
Multimodality imaging findings of pheochromocytoma with associated clinical and biochemical features in 53 patients with histologically confirmed tumors. AJR Am J Roentgenol (2013) 0.82
Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis (2015) 0.82
Don't Forget the Doctor: Gastroenterologists' Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease. JMIR Mhealth Uhealth (2015) 0.82
Alleviating ischemia-reperfusion injury in small bowel. Am J Transplant (2004) 0.82
Disease manifestations of Helicobacter pylori infection in Arctic Canada: using epidemiology to address community concerns. BMJ Open (2014) 0.80
Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease. Liver Int (2014) 0.80
Fulminant hepatic failure necessitating transplantation following the initiation of infliximab therapy: a cautionary tale times two. Transpl Int (2013) 0.79
Complementary, holistic, and integrative medicine: autism spectrum disorder and gluten- and casein-free diet. Pediatr Rev (2013) 0.79
Across genus plasmid transformation between Bacillus subtilis and Escherichia coli and the effect of Escherichia coli on the transforming ability of free plasmid DNA. Curr Microbiol (2007) 0.79
The role of histopathology in diagnosing protracted diarrhea of infancy. Fetal Pediatr Pathol (2010) 0.78
Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease. Inflamm Bowel Dis (2015) 0.78
Small bowel fibrosis and systemic inflammatory response after ileocolonic anastomosis in IL-10 null mice. J Surg Res (2012) 0.78
VSL#3 ® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis. Liver Int (2013) 0.78
Ameliorating small bowel injury using a cavitary two-layer preservation method with perfluorocarbon and a nutrient-rich solution. Am J Transplant (2004) 0.77
The impact of sirolimus on hepatocyte proliferation after living donor liver transplantation. Clin Transplant (2010) 0.77
Helicobacter pylori induces expression and secretion of oncostatin M in macrophages in vitro. Dig Dis Sci (2010) 0.77
Liver transplantation for overlap syndromes of autoimmune liver diseases. Liver Int (2012) 0.76
Pre-pouch ileitis after colectomy in paediatric ulcerative colitis. Acta Paediatr (2008) 0.76
Childhood autism and eosinophilic colitis. Digestion (2010) 0.76
Complete blockade of the renin-angiotensin system in patients with advanced diabetic nephropathy. Diabetes Care (2003) 0.75
Response to letter to the editor. Can J Gastroenterol Hepatol (2014) 0.75
Using metabolomics to decipher probiotic effects in patients with irritable bowel syndrome. J Clin Gastroenterol (2011) 0.75
Challenges in the diagnosis of enteropathy-associated T cell lymphoma. Can J Gastroenterol (2013) 0.75
Prevalence and Outcome of Upper Gastrointestinal Bleeding Post-coronary Artery Bypass Graft. Int J Health Sci (Qassim) (2008) 0.75
The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials. J Pharm Pharm Sci (2017) 0.75
Control of oxidative stress in small bowel: relevance to organ preservation. Surgery (2006) 0.75
Laryngeal collision tumour: pleomorphic adenoma and squamous cell carcinoma. J Otolaryngol Head Neck Surg (2009) 0.75
Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study. Am J Gastroenterol (2017) 0.75
Microscopic colitis in children. Dig Dis Sci (2010) 0.75
10-year review of pediatric intestinal failure: clinical factors associated with outcome. Nutr Clin Pract (2008) 0.75
Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience. Inflamm Bowel Dis (2017) 0.75
A model for partnership and research between the CAG and sponsors. Can J Gastroenterol (2002) 0.75